{"id":174787,"name":"HORIZON PHARMA USA, INC","slug":"horizon-pharma-usa-inc","state":"IL","country":"United States of America","description":"Biopharmaceutical development","totalSpending":210000,"filings":6,"yearlySpending":[{"year":2018,"income":210000}],"issues":["HCR","MMM"],"firms":["CAPITOL HILL STRATEGIES,  LLC"],"lobbyists":["CHARLES BRAIN","A. WOJCIAK","HEATHER MCHUGH","BEAU` SCHUYLER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to orphan drugs and the value of innovative medicines.","Legislation to address opioids manufacturing and distribution\nPandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), vaccines and other various provisions.","H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data.\nH.R. 1625, Consolidated Appropriations Act","Legislation to address opioids manufacturing and distribution\nPandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), vaccines and other various provisions.","H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data.\nH.R. 1625, Consolidated Appropriations Act"],"years":[2018]}